Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):21-30
The COVID-19 pandemic has provided an additional impetus for studying the respiratory microbiome. Dysbiotic changes resulting from the interaction of the SARS-CoV-2 virus with respiratory tract cells can increase the body’s susceptibility to …